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Ovarian clear cell tumors are mostly carcinolmas, while benign and borderline tumors are quite uncommon. The benign and borderline 
clear cell tumors are almost always adenofibromatous, 
and their prognosis is favorable. Extensive sampling is 
essential for benign and borderline tumors to exclude 
areas of invasion. We describe a rare case of ovarian 
borderline clear cell adenofibroma with extensive heml
orrhagic necrosis.
Case
A 52lyearlold postmenopausal woman presented with 
loose stool, urinary frequency, urgency and dysuria for 
one month. She had a medical history of hypertension 
under medical control and a surgical history of abdomil
nal total hysterectomy for leiomyoma and right sall
pingoloophorectomy for an ovarian cyst 2 years previl
ously. On this visit, the abdominal ultrasound revealed 
a 16lcm pelvic cystic tumor with internal echogenecity 
and septae formation. The laboratory study showed an 
elevated CAl125, up to 233.0 U/mL (normal, <35 U/
mL). Due to the impression of an ovarian malignant tul
mor, she received left salpingoloophorectomy, regional 
lymph node dissection, omentectomy, and resection of 
the adhered segment of colon. 
The left ovary sent for pathologic examination 
was fragmented into two pieces, which consisted of 
one separated tumorous tissue fragment measuring 
8.5×5.5×3.2 cm in size, and another tissue fragment 
measuring 12.0×10.0×4.3 cm in size with adhesion to 
the serosa of the colon. The tumor was lobulated, welll
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borderline clear cell adenofibroma of the ovary is rather rare since most of clear cell tumors are carci-
nomas. We report a case of ovarian borderline clear cell adenofibroma in a 52-year-old postmenopausal 
woman. the tumor had the characteristic histologic features of borderline clear cell adenofibroma except 
for central extensive hemorrhagic necrosis. the prognosis of borderline clear cell adenofibroma is excel-
lent. because the invasiveness cannot be assessed in the necrotic areas, our patient needed long-term 
follow-up.
encaspulated, and the outer surface was rough with 
fibrous adhesion and congestion. The cut surface was 
gray to red, and elastic with hemorrhage and congesl
tion. It was predominantly solid with variablelsized 
cysts (Figure 1). Microscopically, the tumor showed 
extensive hemorrhagic necrosis, involving about 80% of 
the tumor area (Figure 2). The viable tumor part was 
composed of variablelsized glands lined by a monolayer 
of flat, cuboidal or hobnail cells and occasionally solid 
nests of cells. The tumor cells exhibited clear or eosinol
philic cytoplasms and nuclear irregularity, hyperchrol
matism and occasionally prominent nucleoli (Figure 3). 
The stroma was densely fibrotic. No evidence of strol
mal invasion was identified in the viable tumor areas. 
A mitotic figure was not found. Endometriosis was not 
present in this case. The pathologic diagnosis was borl
derline clear cell adenofibroma of the ovary. The tumor 
was confined to the left ovary without invasion or mel
tastasis to other sites.
Her postloperative course was smooth, and the CAl
125 level was reduced to normal (9.2 U/mL) 6 months 
later. No evidence of recurrence or metastasis was noted 
during the following 10 months.
DISCUSSION
Ovarian clear cell tumors can display variable cell types 
including hobnail, cuboidal, or columnar cells with clear 
or eosinophilic cytoplasms. They can arrange in a papl
illary, tubulocystic or a solid pattern. According to the 
classification of the World Health Organization, clear 
cell tumors are divided into benign, borderline, and mal
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lignant types. Benign and borderline tumors are nearly 
always adenofibromatous.
Identification of the foci of stromal invasion is somel
times difficult in clear cell adenofibromatous tumors. 
Bell et al1 proposed the criteria of invasion in clear cell 
tumors, which included the presence of glands, small 
solid nests of malignant cells, or single malignant cells 
extending irregularly into the stroma, and/or the presl
ence of a desmoplastic, myxoid, or edematous stromal 
reaction. Our case did not show any of the above. The 
stroma of clear cell adenofibroma is cellular and reseml
bles an ovarian fibroma. If carcinomatous epithelium 
without invasion is present in the borderline tumor, the 
term “borderline clear cell adenofibroma with intraepil
thelial carcinoma” is advised. 
Benign and borderline clear cell adenofibromas are 
assumed to be the precursor lesions of clear cell carl
cinomas.2 There is some genetic evidence discovered 
recently to support this assumption. Yamamoto et al3 
determined that loss of heterozygosities on 5q, 10q and 
22q were frequently present in both clear cell adenol
fibroma and clear cell adenocarcinoma. This indicated 
these genetic alterations may occur early in the tumoril
genesis. In contrast, loss of heterozygosities on 1p and 
13q occurred only in the clear cell adenocarcinoma, 
which meant they were associated with later malignant 
transformation. 
Borderline clear cell adenofibroma only accounts for 
less than 1% of ovarian borderline tumors. Since clear 
cell carcinoma sometimes is accompanied by adenofil
bromatous areas, extensive sampling of any benign or 
borderline clear cell adenofibromas is essential to exl
clude areas of carcinoma. Yamamoto et al4 observed that 
clear cell carcinoma associated with adenofibromatous 
areas was more likely to be low grade, with a a lower Kil
67 proliferation index and a more favorable prognosis. 
Veras et al5 divided clear cell carcinomas into cystic and 
adenofibromatous groups, and discovered that the adl
enofibromatous group was often diagnosed in more adl
vanced stage, showed less frequency with endometriosis, 
less papillary pattern, and a less favorable outcome. The 
prognosis based on the studies of Yamamoto and Veras is 
rather divergent, and this suggests that additional studl
ies on these two groups of clear cell carcinoma should 
be performed in the future. Besides, Yamamoto et al6 
studied two subgroups of clear cell adenocarcinoma, and 
indicated two distinct carcinogenetic pathways: endol
metriosislassociated pathway and adenofibromalassocil
ated pathway. In addition, the frequencies of p27Kip1 
downregulation as well as Skp2 and cyclin A overexpresl
sion were significantly lower in adenofibromalassociated 
carcinomas.7 All the evidence implies that there are two 
Figure 1. The cut surface of the tumor shows multilocular cysts 
with extensive hemorrhage and congestion.
Figure 2. The tumor exhibits extensive hemorrhagic necrosis 
(hematoxyline and eosin stain 40×).
Figure 3. The tumor is composed of variable sized cystic glands 
lined by clear or hobnail cells with nuclear atypia (hematoxylin 
and eosin stain 100×).
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different pathogenetic pathways of ovarian clear cell carl
cinomas. The studies of borderline clear cell tumors can 
also contribute the issue.
The prognosis of patients with borderline clear cell 
adenofibroma is favorable. No definite metastasis has 
been reported. However, due to its rarity, the clinicol
pathologic features of borderline tumors are limited. 
Since the tumor in our patient showed extensive heml
orrhagic necrosis, the invasiveness cannot be evaluated 
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in these areas. We decided the patient should receive 
longlterm followlup to determine the characteristics of 
the tumor.
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